A recent poll found that 12% of Americans about 1 in 8 adults have taken a GLP-1 medication
It cannot prove how one person will respond
, 124 patients undergoing an elective procedure requiring anesthesia, the prevalence of increased residual gastric content was 56% for those taking GLP-1 agonists compared with 19% for those without use of these drugs, reported Sudipta Sen, MD. Dr
GLP-1 Pipeline Update: February 2026 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
This will cover its impact on billing and reimbursement processes, its role in patient access to semaglutide, and its implications for healthcare providers and insurers